This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Almac Discovery Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Lauren Proctor
Introduction
Lauren Proctor is a notable inventor based in Craigavon, GB. She has made significant strides in the field of pharmaceuticals, particularly with her work on compounds that inhibit the activity of the ubiquitin specific protease USP19. Her innovative approach has the potential to impact therapeutic methods significantly.
Latest Patents
Lauren Proctor holds a patent for pharmaceutical compounds, specifically related to compounds of Formula (I). This invention is crucial as it relates to the development of inhibitors for USP19, which can be utilized in various therapeutic applications. The patent showcases her commitment to advancing medical science through innovative solutions.
Career Highlights
Proctor is currently associated with Almac Discovery Limited, where she continues to contribute to groundbreaking research and development in pharmaceuticals. Her work at Almac Discovery Limited emphasizes her dedication to improving healthcare through innovative drug development.
Collaborations
Throughout her career, Lauren has collaborated with esteemed colleagues such as Peter Hewitt and Mary Melissa McFarland. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their field.
Conclusion
Lauren Proctor's contributions to pharmaceutical innovation exemplify the impact of dedicated inventors in advancing medical science. Her work not only highlights her expertise but also underscores the importance of collaboration in achieving significant advancements in healthcare.